Search research articles
Contact Us
Filters
Showing results (71-80 of 167) with videos related to
Page
of 17
Sort By:
Anesthesiology
|
January 21, 2015
Discovery of a novel general anesthetic chemotype using high-throughput screening
Andrew R McKinstry-Wu, Weiming Bu, Ganesha Rai, et al.
Scientific Reports
|
March 8, 2020
A high-throughput screening platform for Polycystic Kidney Disease (PKD) drug repurposing utilizing murine and human ADPKD cells
Rosita R Asawa, Carina Danchik, Alexey Zakharov, et al.
Journal of Medicinal Chemistry
|
June 15, 2010
Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors
Rafaela S Ferreira, Anton Simeonov, Ajit Jadhav, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 3, 2007
Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease
Wei Zheng, Janak Padia, Daniel J Urban, et al.
DNA Repair
|
May 6, 2014
Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platform
Junko Murai, Christophe Marchand, Sampada A Shahane, et al.
Combinatorial Chemistry & High Throughput Screening
|
June 10, 2008
A high throughput fluorescence polarization assay for inhibitors of the GoLoco motif/G-alpha interaction
Adam J Kimple, Adam Yasgar, Mark Hughes, et al.
Biology
|
May 28, 2025
Identifying Molecular Properties of Ataxin-2 Inhibitors for Spinocerebellar Ataxia Type 2 Utilizing High-Throughput Screening and Machine Learning
Smita Sahay, Jingran Wen, Daniel R Scoles, et al.
Frontiers in Pharmacology
|
May 29, 2019
The NCATS BioPlanet - An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical Genomics
Ruili Huang, Ivan Grishagin, Yuhong Wang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 5, 2017
First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis
Reheman Adili, Benjamin E Tourdot, Katherine Mast, et al.
Bioorganic & Medicinal Chemistry
|
February 23, 2016
A potent and selective inhibitor targeting human and murine 12/15-LOX
Michelle M Armstrong, Cody J Freedman, Joo Eun Jung, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 167) with videos related to
Sort By:
Page
of 17
Anesthesiology
|
January 21, 2015
Discovery of a novel general anesthetic chemotype using high-throughput screening
Andrew R McKinstry-Wu, Weiming Bu, Ganesha Rai, et al.
Scientific Reports
|
March 8, 2020
A high-throughput screening platform for Polycystic Kidney Disease (PKD) drug repurposing utilizing murine and human ADPKD cells
Rosita R Asawa, Carina Danchik, Alexey Zakharov, et al.
Journal of Medicinal Chemistry
|
June 15, 2010
Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors
Rafaela S Ferreira, Anton Simeonov, Ajit Jadhav, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 3, 2007
Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease
Wei Zheng, Janak Padia, Daniel J Urban, et al.
DNA Repair
|
May 6, 2014
Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platform
Junko Murai, Christophe Marchand, Sampada A Shahane, et al.
Combinatorial Chemistry & High Throughput Screening
|
June 10, 2008
A high throughput fluorescence polarization assay for inhibitors of the GoLoco motif/G-alpha interaction
Adam J Kimple, Adam Yasgar, Mark Hughes, et al.
Biology
|
May 28, 2025
Identifying Molecular Properties of Ataxin-2 Inhibitors for Spinocerebellar Ataxia Type 2 Utilizing High-Throughput Screening and Machine Learning
Smita Sahay, Jingran Wen, Daniel R Scoles, et al.
Frontiers in Pharmacology
|
May 29, 2019
The NCATS BioPlanet - An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical Genomics
Ruili Huang, Ivan Grishagin, Yuhong Wang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 5, 2017
First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis
Reheman Adili, Benjamin E Tourdot, Katherine Mast, et al.
Bioorganic & Medicinal Chemistry
|
February 23, 2016
A potent and selective inhibitor targeting human and murine 12/15-LOX
Michelle M Armstrong, Cody J Freedman, Joo Eun Jung, et al.
Page
of 17